Akebia Therapeutics Inc (AKBA)
1.155
+0.02
(+1.32%)
USD |
NASDAQ |
May 17, 16:00
1.155
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Price: 1.155 for May 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2024 | 1.13 | 1.18 | 1.12 | 1.15 | 2.349M |
| May 16, 2024 | 1.16 | 1.20 | 1.13 | 1.14 | 3.383M |
| May 15, 2024 | 1.22 | 1.26 | 1.145 | 1.18 | 3.628M |
| May 14, 2024 | 1.26 | 1.268 | 1.20 | 1.23 | 2.216M |
| May 13, 2024 | 1.21 | 1.30 | 1.19 | 1.29 | 2.414M |
| May 10, 2024 | 1.25 | 1.33 | 1.19 | 1.21 | 2.317M |
| May 09, 2024 | 1.11 | 1.33 | 1.03 | 1.33 | 8.227M |
| May 08, 2024 | 1.39 | 1.41 | 1.33 | 1.40 | 2.848M |
| May 07, 2024 | 1.51 | 1.56 | 1.38 | 1.40 | 4.089M |
| May 06, 2024 | 1.41 | 1.50 | 1.40 | 1.49 | 2.336M |
| May 03, 2024 | 1.34 | 1.42 | 1.32 | 1.37 | 3.117M |
| May 02, 2024 | 1.26 | 1.31 | 1.215 | 1.30 | 2.500M |
| May 01, 2024 | 1.25 | 1.30 | 1.24 | 1.24 | 3.111M |
| Apr 30, 2024 | 1.31 | 1.315 | 1.23 | 1.26 | 4.654M |
| Apr 29, 2024 | 1.34 | 1.38 | 1.31 | 1.32 | 1.974M |
| Apr 26, 2024 | 1.32 | 1.35 | 1.29 | 1.34 | 2.476M |
| Apr 25, 2024 | 1.35 | 1.35 | 1.31 | 1.33 | 2.561M |
| Apr 24, 2024 | 1.37 | 1.40 | 1.35 | 1.37 | 1.536M |
| Apr 23, 2024 | 1.38 | 1.41 | 1.35 | 1.37 | 2.109M |
| Apr 22, 2024 | 1.37 | 1.40 | 1.34 | 1.36 | 2.006M |
| Apr 19, 2024 | 1.35 | 1.38 | 1.31 | 1.36 | 2.956M |
| Apr 18, 2024 | 1.37 | 1.435 | 1.33 | 1.39 | 2.563M |
| Apr 17, 2024 | 1.40 | 1.42 | 1.36 | 1.39 | 2.944M |
| Apr 16, 2024 | 1.38 | 1.425 | 1.32 | 1.40 | 4.129M |
| Apr 15, 2024 | 1.42 | 1.45 | 1.39 | 1.39 | 3.898M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.25
Minimum
Nov 29 2022
13.58
Maximum
Jun 30 2020
3.166
Average
2.52
Median
Oct 01 2020
Price Benchmarks
| Aquestive Therapeutics Inc | 3.10 |
| Amicus Therapeutics Inc | 9.57 |
| Insmed Inc | 24.77 |
| Altimmune Inc | 8.01 |
| InfuSystems Holdings Inc | 6.44 |
Price Related Metrics
| PS Ratio | 1.182 |
| Earnings Yield | -19.72% |
| Market Cap | 241.04M |